Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$9,852,118
+$2,192,274 QoQ
Shares Held
8,214
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,267
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOWE BROCKENBROUGH & CO INC holds $62,097,620 across 10 Drug Manufacturers - General names. LLY ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,660 | $12,104,210 | |
| 2 | MRK |
Merck & Co., Inc.
|
91,716 | $11,785,506 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
8,214 | $9,852,118 | |
| 4 | AMGN |
Amgen Inc
|
26,947 | $9,758,047 | |
| 5 | ABBV |
AbbVie Inc.
|
29,181 | $7,343,106 | |
| 6 | PFE |
Pfizer Inc
|
216,527 | $5,213,970 | |
| 7 | NVS |
Novartis AG
|
13,636 | $2,137,033 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,635 | $1,880,428 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,852,118 | 8,214 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,659,844 | 8,328 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,101,465 | 8,469 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,127,360 | 6,720 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,289,111 | 6,785 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,640,965 | 6,830 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,366,172 | 6,951 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,158,168 | 6,951 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $6,183,745 | 6,830 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,558,524 | 7,145 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,927,714 | 6,738 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,644,964 | 6,786 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,299,743 | 7,036 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,465,068 | 7,178 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,557,221 | 6,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,324,886 | 7,190 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,428,482 | 7,490 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,193,021 | 7,658 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,198,158 | 7,958 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,838,695 | 7,958 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,826,520 | 7,958 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,486,713 | 7,958 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,570,212 | 9,300 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,394,348 | 9,420 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,538,366 | 9,370 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,306,742 | 9,420 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||